Tailored thromboprophylaxis for patients with multiple myeloma treated by IMIDs

Leukemia and Lymphoma

Volumn 49, Issue 8, 2008, Pages 1644-1645

  Paydas, Semra ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTINEOPLASTIC AGENT; CLARITHROMYCIN; DEXAMETHASONE; DOXORUBICIN; HEPARIN; IMMUNOMODULATING AGENT; LENALIDOMIDE; LOW MOLECULAR WEIGHT HEPARIN; THALIDOMIDE; WARFARIN;

ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; DEEP VEIN THROMBOSIS; DISEASE CONTROL; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG INDICATION; DRUG RESPONSE; EVIDENCE BASED PRACTICE; HUMAN; LOW DRUG DOSE; MULTIPLE MYELOMA; PATIENT COMPLIANCE; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; RISK REDUCTION; THROMBOSIS;

ASPIRIN; CHEMOPREVENTION; HUMANS; MULTIPLE MYELOMA; THALIDOMIDE; THROMBOSIS;

EID: 51349127396     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190802187155     Document Type: Article

References (3)

1. Niesvizky, R., Martinez, D., Jalbrzikowski, J., Christos, P., Furst, J. Sancho, M. et al. (2007) Prophylactic low-dose aspirin is effective antithrombotic therapy for combination treatments of thalidomide or lenalidomide in myeloma. Leuk Lymphoma, 48, pp. 2330-2337.
2. Palumbo, A., Facon, T., Sonnoveld, P., Blade, J., Offidani, M. Gay, F. et al. (2008) Thalidomide for treatment of multiple myeloma. Blood, 111, pp. 3968-3977.
3. Palumbo, A., Rajkumar, S. V., Dimopoulos, M. A., Richardson, P. G., San Miguel, J Barlogie, B. et al. (2008) Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma. Leukemia, 22, pp. 414-423.